Search Header Logo

Cardiovascular Disease Risk and Severe Psoriasis

Authored by Amnah Almulhim

Other

Professional Development

Used 3+ times

Cardiovascular Disease Risk and Severe Psoriasis
AI

AI Actions

Add similar questions

Adjust reading levels

Convert to real-world scenario

Translate activity

More...

    Content View

    Student View

30 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

1 min • 1 pt

You are discussing the cardiovascular disease risk of a patient with severe psoriasis with her primary care provider. You are asked how the risk of cardiovascular disease associated with severe psoriasis compares to that associated with other risk factors. You explain that the risk of cardiovascular disease that is associated with severe psoriasis is similar to that conferred by which of the following:

Diabetes

Dyslipidemia

Hypertension

Inflammatory bowel disease

Smoking

2.

MULTIPLE CHOICE QUESTION

1 min • 1 pt

What percentage of patients with psoriasis are at risk of developing psoriatic arthritis (PsA)?

10%

20%

30%

50%

3.

MULTIPLE CHOICE QUESTION

1 min • 1 pt

What is the most common genetic susceptibility associated with psoriasis?

HLA-B27

HLA-DR4

HLA-A1

HLA-Cw6

4.

MULTIPLE CHOICE QUESTION

1 min • 1 pt

What type of arthritis is most commonly associated with patients diagnosed with psoriatic arthritis (PsA)?

Reactive arthritis

Erosive arthritis

Inflammatory arthritis

Degenerative arthritis

5.

MULTIPLE CHOICE QUESTION

1 min • 1 pt

What is the maximum recommended body surface area percentage for the application of Tazarotene in the treatment of psoriasis?

5–10%

10–20%

20–30%

30–40%

6.

MULTIPLE CHOICE QUESTION

2 mins • 1 pt

A pregnant woman nearing delivery has been treated with a TNF-alpha inhibitor. What is the recommended course of action regarding the vaccination of her newborn, particularly concerning live vaccines?

The newborn can receive live vaccines immediately after birth without any precautions.

The newborn should not receive live vaccines for at least 18 months after birth due to potential immunosuppression.

The newborn should not receive live vaccines for at least 12 months after birth to avoid risks associated with maternal immunosuppression.

The newborn should follow the standard vaccination schedule without any modifications, as TNF-alpha inhibitors do not affect vaccine safety.

7.

MULTIPLE CHOICE QUESTION

1 min • 1 pt

Media Image

A 56-year-old man comes in for a pruritic skin eruption. A biopsy is performed and shown below. Based on this diagnosis, targeting which cytokine(s) would offer a reasonable treatment strategy for this patient?

IL-31

IL-23 and/or IL-27

IL-23

IL-4 and/or IL-13

IL-4

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?